Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.37 - $1.69 $210,308 - $960,596
568,400 Added 47.15%
1,773,800 $1.38 Million
Q2 2023

Aug 14, 2023

BUY
$0.39 - $1.69 $30,264 - $131,144
77,600 Added 6.88%
1,205,400 $470,000
Q1 2023

May 15, 2023

SELL
$1.75 - $3.14 $942,200 - $1.69 Million
-538,400 Reduced 32.31%
1,127,800 $1.97 Million
Q4 2022

Feb 14, 2023

BUY
$2.09 - $4.32 $205,656 - $425,088
98,400 Added 6.28%
1,666,200 $3.85 Million
Q3 2022

Nov 14, 2022

SELL
$2.24 - $4.18 $1.37 Million - $2.56 Million
-612,600 Reduced 28.1%
1,567,800 $4.28 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.36B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.